Potential Utility of Telmisartan, an Angiotensin II Type 1 Receptor Blocker with Peroxisome Proliferator-Activated Receptor-&ggr; (PPAR-&ggr;)-Modulating Activity for the Treatment of Cardiometabolic Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|7|5|463-469

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.7, Iss.5, 2007-08, pp. : 463-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome Proliferator-Activated Receptor-&ggr; in Vascular Biology

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 109-117

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor  (PPAR) and sepsis

By Knethen Andreas   Soller Mathias   Brüne Bernhard  

Archivum Immunologiae et Therapiae Experimentalis, Vol. 55, Iss. 1, 2007-02 ,pp. : 19-25

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 513-525

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-&ggr; (PPAR-&ggr;) Ligands: Novel Pharmacological Agents in the Treatment of Ischemia Reperfusion Injury

By  

Current Molecular Medicine, Vol. 8, Iss. 6, 2008-01 ,pp. : 562-579

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR) in Regenerative Medicine: Molecular Mechanism for PPAR in Stem Cells’ Adipocyte Differentiation

By  

Current Stem Cell Research & Therapy, Vol. 11, Iss. 3, 2016-04 ,pp. : 290-298

Bentham Science Publishers

Access to resources Recommend Favorite